Fifty 1 Labs Subsidiary Partners with LUNR Aerospace to Develop AI-Driven Space Medicine Solutions
Fifty 1 Labs' subsidiary Fifty 1 AI Labs has partnered with LUNR Aerospace to advance AI-driven drug repurposing for space medicine, addressing critical health challenges in microgravity while positioning the company to capitalize on the rapidly growing space medicine market projected to reach $1.97 billion by 2032.
Read the full story